Table 2: Inclusion and exclusion criteria.
| TOTAL | Immunized patients | Patients not immunized | Immunized controls | Controls not immunized | |
| Cases | 59 | 20 | 23 | 6 | 10 |
| Gender M: H (%) | 39 (68.4%):18 (31.6%) | 15:5 | 13:10 | 3:1 | 8:2 |
| Middle Ages (years) | 45.9 (+/- 16) | 51.5 (+/- 14.3) | 48.7 (+/- 14.8) | 47.5 (+-/ 19.3) | 27.8 (+/- 7.1) |
| Tumour type | Breast (41.9%) Prostate (9.3%) Colon (9.3%) Cervix (4.7%) Gastric (4.7%) Osteosarcoma (4.7%) Ovary (4.7%) Sarcoma (4.7%) Seminoma (4.7%) Thyroid (4.7%) Melanoma (2.3%) Parotid (2.3%) Lung (2.3%) |
Breast (55%) Colon (10%) Osteosarcoma (10%) Prostate (10%) Sarcoma (5%) Seminoma (5%) Thyroid (5%) |
Breast (30.4%) Cervix (8.7%) Colon (8.7%) Gastric (8.7%) Ovary (8.7%) Prostate (8.7%) Melanoma (4.3%) Parotid (4.3%) Lung (4.3%) Sarcoma (4.3%) Seminoma (4.3%) Thyroid (4.3%) |
N/A | N/A |
| Tumoral Stadium (%) | I: 2% II: 33% III: 37% IV: 28% |
I: 25% II: 40% III: 5% IV: 30% |
I: 13% II: 47.8% III: 30.4% IV: 8.6% |
N/A | N/A |